Lytix Biopharma AS (OSL: LYTIX)
Norway
· Delayed Price · Currency is NOK 5.74
-0.02 (-0.35%)
Jan 17, 2025, 4:03 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 287.74 million as of January 21, 2025. Its market cap has increased by 44.20% in one year.
Market Cap
287.74M
Enterprise Value
247.03M
Revenue
10.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.74
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 287.74M, a decrease of -60.07%. That is a compound annual growth rate of -22.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 287.74M | -1.36% |
| Dec 30, 2024 | 291.71M | 49.80% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 3.43B |
| Medistim ASA | 2.72B |
| Photocure ASA | 1.46B |
| Hofseth BioCare ASA | 1.20B |
| Vistin Pharma ASA | 1.00B |
| Nykode Therapeutics AS | 877.10M |
| ArcticZymes Technologies ASA | 715.00M |
| Omda AS | 680.06M |